Fluticasone propionate and atopic dermatitis

被引：0
|
作者：
Sarbjit S. Saini
机构：
来源：
Current Allergy and Asthma Reports | 2004年 / 4卷 / 4期
关键词：
Atopic Dermatitis; Fluticasone; Fluticasone Propionate; Maintenance Phase; Topical Steroid;
D O I：
10.1007/s11882-004-0067-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：261 / 261
相关论文
共 50 条
  • [31] PLUME CHARACTERISTICS OF FLUTICASONE PROPIONATE/FORMOTEROL PMDI COMPARED WITH FLUTICASONE PROPIONATE/SALMETEROL PMDI
    Johal, Baljinder
    Murphy, Seamus
    Marshall, Jonathan
    RESPIROLOGY, 2013, 18 : 17 - 17
  • [32] Plume characteristics of fluticasone propionate/formoterol pMDI compared with fluticasone propionate/salmeterol pMDI
    Johal, Baljinder
    Murphy, Seamus
    Marshall, Jonathan
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [33] Glucocorticoid receptors and fluticasone propionate
    Hogger, P
    Rohdewald, P
    REVIEWS IN CONTEMPORARY PHARMACOTHERAPY, 1998, 9 (08): : 501 - 522
  • [34] ANTIINFLAMMATORY PROPERTIES OF FLUTICASONE PROPIONATE
    JOHNSON, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 439 - 440
  • [35] ORAL AVAILABILITY OF FLUTICASONE PROPIONATE
    ANDERSSON, P
    BRATTSAND, R
    DAHLSTROM, K
    EDSBACKER, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (02) : 135 - 136
  • [36] Fluticasone propionate bioavailability in asthma
    Crompton, GK
    LANCET, 2000, 356 (9242): : 1681 - 1682
  • [37] Montelukast and fluticasone propionate - Response
    Bukstein, DA
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (06) : 586 - 587
  • [38] Fluticasone propionate: Safety profile
    Johnson, M
    CUTIS, 1996, 57 : 10 - 12
  • [39] THE ANTIINFLAMMATORY PROFILE OF FLUTICASONE PROPIONATE
    JOHNSON, M
    ALLERGY, 1995, 50 (23) : 11 - 14
  • [40] The clinical pharmacology of fluticasone propionate
    Meibohm, B
    Mollmann, H
    Wagner, M
    Hochhaus, G
    Mollmann, A
    Derendorf, H
    REVIEWS IN CONTEMPORARY PHARMACOTHERAPY, 1998, 9 (08): : 535 - 549
12345